Mepi Mynol (Epinephrine Bitartrate, Mepivacaine Hydrochloride)

Mepi Mynol, a local anesthetic combination, is used for infiltration anesthesia in minor surgical and dental procedures.

• Minor surgical procedures: provides localized numbness to facilitate incision and tissue manipulation.
• Dental procedures: enables pain control during extractions, root canals and restorative work.
• Dermatologic minor procedures: allows anesthesia for skin biopsies, lesion excisions and cosmetic interventions.

• Mepivacaine blocks voltage‑gated sodium channels on neuronal membranes, preventing propagation of nerve impulses and producing loss of sensation. Epinephrine Bitartrate stimulates α‑adrenergic receptors causing vasoconstriction, which reduces systemic absorption of the anesthetic, prolongs its effect, and limits bleeding at the injection site.

Mepi Mynol may cause a range of adverse reactions following infiltration.

Common Side Effects

• Transient pain or burning at the injection site.
• Tingling, numbness or mild paresthesia in the treated area.
• Temporary increase in blood pressure or heart rate.
• Mild dizziness or light‑headedness.
• Nausea or mild gastrointestinal upset.

Serious or Rare Side Effects

• Allergic reaction including anaphylaxis.
• Cardiac arrhythmias or severe tachycardia.
• Significant hypotension or hypertensive crisis.
• Seizures due to excessive local anesthetic systemic toxicity.
• Persistent numbness or motor weakness beyond the expected duration.

Before using Mepi Mynol, consider the following safety measures.

• Assess patient allergy: verify no known hypersensitivity to amide‑type local anesthetics or epinephrine.
• Monitor cardiovascular status: observe for tachycardia, hypertension or arrhythmias during and after injection.
• Use caution in hyperthyroid patients: epinephrine may exacerbate symptoms.
• Limit dosage in severe liver disease: reduced metabolism can increase systemic exposure.
• Avoid use in pregnancy unless benefits outweigh risks, as safety data are limited.
• Store at ambient temperature: keep in original container, protect from light and moisture.

Mepi Mynol can interact with other medications; awareness of the severity helps guide management.

Major Interactions (Avoid)

• Non‑selective beta‑blockers: may potentiate epinephrine‑induced hypertension.
• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
• Tricyclic antidepressants: increased cardiovascular stimulation.

Moderate Interactions (Monitor Closely)

• Concurrent local anesthetics: additive toxicity risk.
• Sympathomimetic drugs (e.g., phenylephrine): may enhance vasoconstriction.
• Diuretics: may alter plasma concentration of the anesthetic components.